SEER
Seer, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.89
−1.82%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.26
- Revenue estimate
- $4.2M
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.31
- EPS estimate
- -$0.27
- Revenue actual
- $3.1M
- Revenue estimate
- $3.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -0.3%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.27 | -$0.31 | Miss -14.81% | $3.1M |
| May 13, 2026 | -$0.29 | -$0.30 | Miss -1.69% | $2.8M |
| Nov 6, 2025 | -$0.32 | -$0.32 | In line | $4.1M |
| Aug 6, 2025 | -$0.39 | -$0.33 | Beat 15.38% | $4.1M |
| Feb 27, 2025 | -$0.31 | -$0.34 | Miss -9.68% | $3.9M |
| Aug 8, 2024 | -$0.36 | -$0.35 | Beat 2.78% | $3.1M |
| Feb 29, 2024 | -$0.35 | -$0.28 | Beat 20.00% | $4.2M |
| Mar 2, 2023 | -$0.42 | -$0.36 | Beat 14.29% | $3.9M |
| May 4, 2022 | -$0.41 | -$0.38 | Beat 7.32% | $3.3M |
| Feb 28, 2022 | -$0.34 | -$0.32 | Beat 5.88% | $3.0M |
| Aug 12, 2021 | -$0.28 | -$0.27 | Beat 3.57% | $1.2M |
| Dec 4, 2020 | — | -$0.17 | — | $71.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026